The parent company of Fujifilm Medical Systems USA plans to spend 500 billion yen ($4.54 billion U.S.) on mergers and acquisitions over the next three years as it seeks to diversify from its core photography business, according to an article published August 29 by Reuters.
Fujifilm Holdings is seeking growth outside of its traditional photography business, which has been declining, according to the story. Reuters noted that in December, Fujifilm announced a deal to buy Wako Pure Chemical Industries from Takeda Pharmaceuticals for $1.3 billion.
In 2016, Fujifilm was one of the bidders for Toshiba's medical systems business, but it was outbid by Canon.
